Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
Myrthe M A TooropQingui ChenVladimir Y I G TichelaarSuzanne C CannegieterWillem M LijferingPublished in: European heart journal (2021)
At least a quarter of NVAF patients were non-persistent with OACs within 4 years, which was associated with poor efficacy of ischaemic stroke prevention. The identified baseline characteristics may help identify patients at risk of non-persistence.
Keyphrases
- atrial fibrillation
- end stage renal disease
- oral anticoagulants
- ejection fraction
- chronic kidney disease
- newly diagnosed
- catheter ablation
- direct oral anticoagulants
- left atrial
- peritoneal dialysis
- left atrial appendage
- heart failure
- prognostic factors
- venous thromboembolism
- cross sectional
- metabolic syndrome
- aortic valve
- adipose tissue
- left ventricular
- weight loss